-
Alternative_name
4-[1-(6-Quinolinylmethyl)-1H-1,2,3-triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazole-1-ethanol
-
Description
PF-04217903 is a novel ATP-competitive small-molecule inhibitor of c-Met kinase. PF-04217903 displays more than 1,000-fold selectivity for c-Met compared with more than 150 kinases. PF-04217903 inhibits tumor cell proliferation, survival, migration/invasion in MET-amplified cell lines in vitro and shows marked antitumor activity in tumor models harboring either MET gene amplification or a hepatocyte growth factor (HGF)/c-Met autocrine loop at well-tolerated dose levels in vivo.
-
CAS Number
956905-27-4
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₁₉H₁₆N₈O
-
Molecular Weight
372.4
-
Cell Permeable
Yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO
-
Handling
Protect from air and light
-
Tag Line
A novel ATP-competitive c-Met kinase inhibitor
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
36 months
-
PubChem CID
7754438
-
-
SMILES
C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1
-
InChi
InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2
-
InChi Key
PDMUGYOXRHVNMO-UHFFFAOYSA-N
-
-
MSDS Available
Yes